← Open Payments lookup

JEFFREY KLOPPER: Open Payments

NPI 1033282017 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,698 in 126 payments from 17 companies in 2025. Trend: 2023 $3,923 · 2024 $2,848 · 2025 $3,698

Food & beverage: $3,583Education: $115
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.24$820
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$682
Alkermes, Inc.17$501
Teva Pharmaceuticals USA, Inc.23$434
Vanda Pharmaceuticals Inc.14$382
Janssen Pharmaceuticals, Inc3$187
E.R. Squibb & Sons, L.L.C.3$173
Luye Pharma (USA) Ltd.3$163
Axsome Therapeutics, Inc.4$128
Otsuka America Pharmaceutical, Inc.3$60

Products named: INGREZZA, CAPLYTA, FANAPT, ARISTADA, UZEDY, COBENFY, ERZOFRI EXTENDED-RELEASE, Auvelity.

Industry payments across GA — which companies pay providers there.